u/tomas_broberg

DEXA has a real error margin and people quote it to one decimal

Correction: that is glucose-dependent insulin secretion, which is why hypoglycaemia risk is low as monotherapy. Not the same claim as you made.

Kept a one-line-a-day log for two months. The pattern was obvious on paper and invisible in my head.

strength retention is a decent proxy and it is free

Same pattern here. It settled at a stable dose without me doing anything clever.

Cosigning on discharge at goal. It catches people who have done everything right and did not know it was coming.

sulphur burps are unpleasant and they are not dangerous

Disagree. That is a preclinical finding in a rodent model and you are stating it as human pharmacology.

Mine settled at week 62 and has not come back since, across two more steps.

Do you have the paper, or a summary of it?

Is this a discharge back to the GP, or a discontinuation?

ask the pharmacy for the price list, not the headline offer

Small fix — that is the Scottish pathway. The post is asking about England and the answer is different.

Correcting myself: the referral was 8 months ago, not the figure I gave. I keep rounding it down.

tier 3 waiting lists are measured in years, not months

Are you comparing against your own baseline or against a published average?

Disagree.

Agreed — and it is why the central and peripheral stories are complementary rather than rival.

That reads like advice, and none of us can give it. Describe what you did, not what somebody else should do.

A symptom that begins the day after the shot and fades by day four tracks the exposure curve. One that appears at random in week 82 probably does not, and that is worth saying to a clinician rather than to us.

discharge at goal back to the GP is where a lot of people fall over

Same pattern here. It settled at a stable dose without me doing anything clever.

Nothing in this thread is medical advice, including this comment. I am describing a mechanism, not telling anybody what to do about their own week.

the scale cannot distinguish tissue types and never could

ahmed_fonseca is right that protein becomes a logistics problem when appetite drops.

Push back: strength dropping in a deficit is not the same as lean mass loss. Related, not identical.

fibre and water before you buy anything to fix it

Constipation is mostly reduced intake plus reduced fluid, not a direct effect. That is why the boring fibre and water answer keeps working.

Registration by the therapeutic goods regulator establishes that a product may be supplied. Subsidy listing is a separate decision about public funding, with its own criteria and its own timetable.

Yes. Nobody here is prescribing training or nutrition and the good posts say so.

sulphur burps are unpleasant and they are not dangerous

ferran_dahlberg is right about the timing. The day-of-week pattern is the diagnostic bit, not the severity.

Has anything else changed in the same window?

Right, and the hair thing is worth repeating: it tracks the rate of loss rather than the compound, and it stops.

Agreed. Registration and subsidy are separate decisions and half the confusion here is treating them as one.

Compounded supply arrangements have changed materially in recent years. Advice predating that change describes a situation that no longer applies.

Nobody warned me about reflux and I would have liked the warning. It was not dangerous, it was just deeply unpleasant and completely unexpected.

the Irish scheme cap is the single most useful fact in this board

That study was in a rodent model. Worth stating, since the thread has been reading it as human data.

DEXA has a real error margin and people quote it to one decimal

Disagree. Severe abdominal pain is not on the list of things to wait out, and this board should not be treating it as one.

Retitled — the original claimed a composition change the scans cannot distinguish.

Agreed — and same machine, same conditions, or the two scans are not comparable.

pharmacy stock and national supply are different questions